Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.

The pharmacogenomics journal - 1 Feb 2014

Kambeitz J, Romanos M, Ettinger U

Abstract excerpt

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent childhood-onset neuropsychiatric disorder. Treatment with methylphenidate, which blocks dopamine and noradrenaline transporters, is clinically efficacious in reducing the symptoms of ADHD. However, a considerable proportion of patients show no or only insufficient response to methylphenidate. Following a pharmacogenetic approach, a number of studies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Attention Deficit Disorder with Hyperactivity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dopamine Plasma Membrane Transport Proteins

Share to Dopamine Uptake Inhibitors

Share to Methylphenidate

Share to Polymorphism, Genetic

Share to Tandem Repeat Sequences

Share to Treatment Outcome

Source

Identifiers

PMID: 23588108
DOI: 10.1038/tpj.2013.9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.PMID 23588108Read ↗

Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).Semantic proximity Read ↗

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).Semantic proximity Read ↗

Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.Semantic proximity Read ↗

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.Semantic proximity Read ↗

Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.Semantic proximity Read ↗

Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.Semantic proximity Read ↗

DRD4 exon 3 genotype and ADHD: Randomised pharmacodynamic investigation of treatment response to methylphenidate.Semantic proximity Read ↗

A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.Semantic proximity Read ↗

Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.Semantic proximity Read ↗

Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder.Semantic proximity Read ↗

The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHDSemantic proximity Read ↗

Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.